Canada Psychedelic Drugs Market to 2032
Overview
The Canada Psychedelic Drugs Market is expected to reach a 50.39 USD Billion by 2032 and is projected to grow at a CAGR of 15.81% from 2025 to 2032.
Revenue, 2024 (USD Billion)
20.11
Forecast, 2032 (USD Billion)
50.39
CAGR, 2024 - 2032
15.81%
Report Coverage
Canada
Canada Psychedelic Drugs Market 2018-2032 USD Billion
Canada Psychedelic Drugs Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 20.11 USD Billion
- Projected Market Size (2032): 50.39 USD Billion
- CAGR (2025-2032): 15.81%
Key Findings of Canada Psychedelic Drugs Market
- The Canada Psychedelic Drugs Market was valued at 20.11 USD Billion in 2024.
- The Canada Psychedelic Drugs Market is likely to grow at a CAGR of 15.81% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Synthetic in Source Segment accounted for the largest share of the market with a revenue of 20.11 USD Billion
- The fastest growing segment Post-Traumatic Stress Disorder in Application Segment grew Fastest with a CAGR of 19.24% during the forecast period from 2024 to 2032.
Canada Psychedelic Drugs Market Scope
Canada Psychedelic Drugs Market Segmentation & Scope
End User
- Others
- Homecare
- Specialty Clinics
- Hospitals
Distribution Channel
- Online Pharmacy
- Retail Pharmacy
- Hopitals Pharmacy
Source
- Natural
- Synthetic
Type
- Others
- Dissociatives
- Empathogens
Drugs
- Psilocybin
- Others
- Ketamine
- Gamma-Hydroxybutyric Acid
Application
- Post-Traumatic Stress Disorder
- Others
- Opiate Addiction
- Major Depressive Disorder
- Treatment Resistant Depression
- Narcolepsy
Route of Administration
- Injectable
- Inhalation
- Oral
Canada Psychedelic Drugs Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2022 |
| Unit | Revenue in USD Billion |
| Market Value in 2024 | 20.11 USD Billion |
| Market Value in 2032 | 50.39 USD Billion |
| CAGR (2025-2032) | 15.81% |
| Historic Data | 2016-2023 |
| Market Segments Covered | End User,Distribution Channel,Source,Type,Drugs,Application,Route of Administration |
Regional Insights:
-
Leading Market (2024-2032): Canada, leading in terms of revenue 20.11 USD Billion in 2024
- Key Country: Canada, leading in terms of revenue with value of 20.11 USD Billion in 2024.
Segments and Scope
-
Canada Psychedelic Drugs Market to 2032, By End User
- Hospitals is the largest segment in Canada Psychedelic Drugs Market to 2032 with a revenue of 11.54 USD Billion in the year 2024.
- Hospitals is the Fastest growing segment in Canada Psychedelic Drugs Market to 2032 with a Growth rate of 16.53 % in forecast period 2025-2032.
-
Canada Psychedelic Drugs Market to 2032, By Distribution Channel
- Hopitals Pharmacy is the largest segment in Canada Psychedelic Drugs Market to 2032 with a revenue of 13.61 USD Billion in the year 2024.
- Hopitals Pharmacy is the Fastest growing segment in Canada Psychedelic Drugs Market to 2032 with a Growth rate of 16.58 % in forecast period 2025-2032.
-
Canada Psychedelic Drugs Market to 2032, By Source
- Synthetic is the largest segment in Canada Psychedelic Drugs Market to 2032 with a revenue of 20.11 USD Billion in the year 2024.
- Synthetic is the Fastest growing segment in Canada Psychedelic Drugs Market to 2032 with a Growth rate of 15.81 % in forecast period 2025-2032.
-
Canada Psychedelic Drugs Market to 2032, By Type
- Empathogens is the largest segment in Canada Psychedelic Drugs Market to 2032 with a revenue of 15.01 USD Billion in the year 2024.
- Empathogens is the Fastest growing segment in Canada Psychedelic Drugs Market to 2032 with a Growth rate of 16.30 % in forecast period 2025-2032.
-
Canada Psychedelic Drugs Market to 2032, By Drugs
- Gamma-Hydroxybutyric Acid is the largest segment in Canada Psychedelic Drugs Market to 2032 with a revenue of 15.13 USD Billion in the year 2024.
- Gamma-Hydroxybutyric Acid is the Fastest growing segment in Canada Psychedelic Drugs Market to 2032 with a Growth rate of 16.02 % in forecast period 2025-2032.
-
Canada Psychedelic Drugs Market to 2032, By Application
- Narcolepsy is the largest segment in Canada Psychedelic Drugs Market to 2032 with a revenue of 12.12 USD Billion in the year 2024.
- Post-Traumatic Stress Disorder is the Fastest growing segment in Canada Psychedelic Drugs Market to 2032 with a Growth rate of 15.01 % in forecast period 2025-2032.
-
Canada Psychedelic Drugs Market to 2032, By Route of Administration
- Oral is the largest segment in Canada Psychedelic Drugs Market to 2032 with a revenue of 15.55 USD Billion in the year 2024.
- Oral is the Fastest growing segment in Canada Psychedelic Drugs Market to 2032 with a Growth rate of 16.78 % in forecast period 2025-2032.
Canada Psychedelic Drugs Market Company Share Analysis
| Company Name |
|
||
| Medtronic | |||
| Jazz Pharmaceuticals, Inc. | |||
| Janssen Global Services, LLC | |||
| ICU Medical, Inc. | |||
| Stryker | |||
Canada Psychedelic Drugs Market Geographical Sales Distribution, 2018-2032 USD Billion
Canada Psychedelic Drugs Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The Canada Psychedelic Drugs Market is segmented based on Segmentation End User,Distribution Channel,Source,Type,Drugs,Application,Route of Administration.
Canada Psychedelic Drugs Market was valued at USD 20.11(Revenue in USD Billion) in 2022.
Canada Psychedelic Drugs Market is projected to grow at a CAGR of 15.81% during the forecast period of 2024 to 2032.
The Synthetic segment is expected to dominate the Canada Psychedelic Drugs Market, holding a largest market share of 20.11 USD Billion in 2024
Canada Psychedelic Drugs Market Scope
Canada Psychedelic Drugs Market Segmentation & Scope
End User
- Others
- Homecare
- Specialty Clinics
- Hospitals
Distribution Channel
- Online Pharmacy
- Retail Pharmacy
- Hopitals Pharmacy
Source
- Natural
- Synthetic
Type
- Others
- Dissociatives
- Empathogens
Drugs
- Psilocybin
- Others
- Ketamine
- Gamma-Hydroxybutyric Acid
Application
- Post-Traumatic Stress Disorder
- Others
- Opiate Addiction
- Major Depressive Disorder
- Treatment Resistant Depression
- Narcolepsy
Route of Administration
- Injectable
- Inhalation
- Oral
Frequently Asked Questions
The Canada Psychedelic Drugs Market is segmented based on Segmentation End User,Distribution Channel,Source,Type,Drugs,Application,Route of Administration.
Canada Psychedelic Drugs Market was valued at USD 20.11(Revenue in USD Billion) in 2022.
Canada Psychedelic Drugs Market is projected to grow at a CAGR of 15.81% during the forecast period of 2024 to 2032.
The estimated market value of the Canada Psychedelic Drugs Market for final year is USD 50.39 (USD Billion).
Canada Psychedelic Drugs Market Company Profiling
Frequently Asked Questions
The Canada Psychedelic Drugs Market is segmented based on Segmentation End User,Distribution Channel,Source,Type,Drugs,Application,Route of Administration.
Canada Psychedelic Drugs Market was valued at USD 20.11(Revenue in USD Billion) in 2022.
Canada Psychedelic Drugs Market is projected to grow at a CAGR of 15.81% during the forecast period of 2024 to 2032.
The estimated market value of the Canada Psychedelic Drugs Market for final year is USD 50.39 (USD Billion).
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.